CLASS II Drug recall · Reported 9 Nov 2016 · FDA Enforcement Report

Desoximetasone Cream recalled by Taro Pharmaceuticals

Taro Pharmaceuticals is recalling Desoximetasone Cream USP, 05%, distributed in Puerto Rico. The recall was initiated on 13 Sep 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: E0598-19624, E5099-19624, Exp. Jan 2017
NDC51672-1261, 51672-1271, 51672-1270
Quantity recalled6,756 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0117-2017
FDA event ID
75349
Recalling firm
Taro Pharmaceuticals, Brampton
Manufacturer
Sun Pharmaceutical Industries, Inc.
Classification
Class II
Status
Terminated
Recall initiated
13 Sep 2016
FDA classified
1 Nov 2016
Reported
9 Nov 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Sep 2016Recall initiated by company
1 Nov 2016Classified by FDA+49 days
9 Nov 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7

Where it was distributed

US & Puerto Rico

Puerto Rico

Questions about this recall

Is Desoximetasone Cream USP, 05% recalled?

Yes. Taro Pharmaceuticals recalled Desoximetasone Cream USP, 05% on 13 Sep 2016. The recall is Class II and its status is Terminated. Recall number D-0117-2017.

Why was it recalled?

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Which lots are affected?

Lot #: E0598-19624, E5099-19624, Exp. Jan 2017

Where was it sold?

US & Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Taro Pharmaceuticals

All 4

Other Desoximetasone recalls

All 10